J. Reuss, P. Kunk, A. Stowman, A. Gru, C. Slingluff et al., Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature, Journal for ImmunoTherapy of Cancer, vol.2, issue.2, p.94, 2016.
DOI : 10.1001/jamaoncol.2015.4368

K. Suozzi, M. Stahl, C. Ko, A. Chiang, S. Gettinger et al., Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy, JAAD Case Reports, vol.2, issue.3, pp.264-272, 2016.
DOI : 10.1016/j.jdcr.2016.05.002
URL : https://doi.org/10.1016/j.jdcr.2016.05.002

F. Danlos, C. Pages, B. Baroudjian, L. Vercellino, M. Battistella et al., Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With??Advanced Melanoma, Chest, vol.149, issue.5, pp.133-139, 2016.
DOI : 10.1016/j.chest.2015.10.082

H. Montaudie, J. Pradelli, T. Passeron, J. Lacour, and S. Leroy, Pulmonary sarcoid-like granulomatosis induced by nivolumab, British Journal of Dermatology, vol.22, issue.4, pp.1060-1063, 2017.
DOI : 10.1158/1078-0432.CCR-15-1136

J. Brahmer, K. Reckamp, P. Baas, L. Crino, W. Eberhardt et al., Nivolumab versus Docetaxel in Advanced Squamous-Cell Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.373, issue.2, pp.123-158, 2015.
DOI : 10.1056/NEJMoa1504627

S. Cousin, M. Toulmonde, M. Kind, A. Cazeau, D. Bechade et al., Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab, Annals of Oncology, vol.32, issue.(4), pp.1178-1187, 2016.
DOI : 10.1200/JCO.2011.39.3298
URL : https://academic.oup.com/annonc/article-pdf/27/6/1178/6678281/mdw125.pdf

J. Cotliar, C. Querfeld, W. Boswell, N. Raja, D. Raz et al., Pembrolizumab-associated sarcoidosis, JAAD Case Reports, vol.2, issue.4, pp.290-293, 2016.
DOI : 10.1016/j.jdcr.2016.06.004
URL : https://doi.org/10.1016/j.jdcr.2016.06.004

M. Birnbaum, M. Ma, S. Fleisig, S. Packer, B. Amin et al., Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma, JAAD Case Reports, vol.3, issue.3, pp.208-219, 2017.
DOI : 10.1016/j.jdcr.2017.02.015
URL : https://doi.org/10.1016/j.jdcr.2017.02.015

N. Braun, L. Celada, J. Herazo-maya, S. Abraham, G. Shaginurova et al., T-Cell Proliferative Capacity, American Journal of Respiratory and Critical Care Medicine, vol.5, issue.5, pp.560-71, 2014.
DOI : 10.1158/1078-0432.CCR-12-2063

A. Garcia-diaz, D. Shin, B. Moreno, J. Saco, H. Escuin-ordinas et al., Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression, Cell Reports, vol.19, issue.6, pp.1189-201, 2017.
DOI : 10.1016/j.celrep.2017.04.031
URL : https://doi.org/10.1016/j.celrep.2017.04.031

P. Sakthivel and D. Bruder, Mechanism of granuloma formation in sarcoidosis, Current Opinion in Hematology, vol.24, issue.1, pp.59-65, 2017.
DOI : 10.1097/MOH.0000000000000301

A. Khan, E. Hams, A. Floudas, T. Sparwasser, C. Weaver et al., PD-L1hi B cells are critical regulators of humoral immunity, Nature Communications, vol.286, issue.1, p.5997, 2015.
DOI : 10.1074/jbc.M110.188599
URL : http://www.nature.com/articles/ncomms6997.pdf